The High Court made a Group Litigation Order on 10 June 2026 in relation to the Johnson & Johnson Baby Powder Litigation.
Baby Powder is a talc based cosmetic product that was sold within the United Kingdom between 1925 and 2023.
This group action is brought by women and men claiming that Baby Powder has caused injury, in the form of mesothelioma and cancers of the epithelium of the ovaries, fallopian tube, and peritoneum. The group action concerns products supplied for sale in the United Kingdom in and after 1965. Claims are also brought by the relatives of deceased who died from these conditions.
The Court appointed KP Law Limited as the Lead Solicitors to the group action.
If you believe you have been affected by Johnson’s Baby Powder, please contact our dedicated legal team to speak about joining the Johnson & Johnson Baby Powder Litigation.
Contact Telephone Number: 0161 710 3085
Contact Email Address: info@kpl.co.uk
It is important that you contact the Lead Solicitors as soon as possible as delay may prejudice your potential claim. The cut-off date for issuing Claim Forms is 4pm on 18 January 2027, the Claim Forms must be served within 7 days of the Claimant receiving the sealed Claim Form from the Court and the cut-off date for entering new claims on the Johnson & Johnson Baby Powder Litigation Group Register is 4pm on 22 March 2027.
This advertisement is published by order of the High Court of Justice.
This development comes despite Harrods previously stating that it accepted vicarious liability for the ‘despicable… Read More
The claim launched against Harrods could be valued as high as £150 million. KP Law… Read More
KP Law, the law firm representing more than 275 survivors in their abuse and exploitation… Read More
The Competition Appeal Tribunal (CAT) has certified collective proceedings against Google on an opt-out basis,… Read More
KP Law has today announced the launch of a potential claim on behalf of individuals… Read More
KP Law is representing thousands of individuals who have developed cancer following prolonged use of… Read More